Research Article
Volume 5 Issue 4 - 2021
Dietary Patterns and Economic and Geographic Risk Factors for the Burden of Diabetes Mellitus (Observational Study)
Lyudmila Alexandrovna Radkevich1* and Dariya Andreyevna Radkevich2
1Doctor of Biological Sciences, Chief Researcher, Center for Theoretical Problems of Physicochemical Pharmacology of the Russian Academy of Sciences, Russia
2Specialist (Physicist), Analyst, Center for Theoretical Problems of Physicochemical Pharmacology of the Russian Academy of Sciences, Russia
*Corresponding Author: Lyudmila Alexandrovna Radkevich, Doctor of Biological Sciences, Chief Researcher, Center for Theoretical Problems of Physicochemical Pharmacology of the Russian Academy of Sciences, Russia.
Received: March 31, 2021; Published: April 28, 2021




Abstract

Purpose: To analyze quality of life, dietary patterns, and metabolic syndrome in countries with the lowest and highest burden of diabetes mellitus (DM2).

Methods and Results: Using the Mann-Whitney U-criterion, we found that the minimum (25 countries) and maximum (25 countries) of 158 countries with DM2 burden was 4-fold different for men in 2004: 186 ± 33 versus 650 ± 122 DALYs (p ≤ 0.0001). There was no difference between country groups in terms of per capita income in 2000. But countries of Group 1 were located in northern latitudes, 49° ± 11°; countries of Group 2 were located in southern latitudes, 14° ± 12° (p ≤ 0.001).

The MS predictors - overweight, obesity, hyperglycemia, and LPA - had no statistical differences between Groups 1 and 2. However, overweight and obesity combined accounted for 80% of the population in both groups 1 and 2.

Hyperlipidemia and BP were 2-fold higher in group 1 (p ≤ 0.0001).

In group 1, there was 1.5 to 4-fold higher consumption: TDC, AP; CV, FS and AB (p ≤ 0.0001).

Conclusion: DM2 burden was 4 times higher in group 2 than in group 1. However, food consumption levels, quality of life and hyperlipidemia were on average 2 times higher in group 1. Obesity and overweight did not differ between country groups, but reached 80% of the populations in both group 1 and 2. Thus, the DM2 burden was 4-fold higher in countries with low quality of life, low food consumption, and low hyperlipidemia.

 

Keywords: Food Consumption Levels; Dietary Patterns; Predictors of Metabolic Syndrome; Burden of Cardiovascular Diseases; Diabetes and Liver Cirrhosis

References

  1. Després JP. “Intra-abdominal obesity: an untreated risk factor for Type 2 diabetes and cardiovascular disease”. Journal of Endocrinological Investigation (2006).
  2. Pandey A., et al. “Type-2 diabetes: Current understanding and future perspectives”. IUBMB Life7 (2015): 506-513.
  3. Balakumar P., et al. “Prevalence and prevention of cardiovascular disease and diabetes mellitus”. Pharmacological Research 113 (2016): 600-609.
  4. Glovaci D., et al. “Epidemiology of Diabetes Mellitus and Cardiovascular Disease”. Current Cardiology Reports 4 (2019): 21.
  5. Arocha Rodulfo JI. “Sedentary lifestyle a disease from xxi century”. Clínica e Investigación en Arteriosclerosis 5 (2019): 233-240.
  6. Biykem Bozkurt., et al. “Contributory Risk and Management of Comorbidities of Hypertension, Obesity, Diabetes Mellitus, Hyperlipidemia, and Metabolic Syndrome in Chronic Heart Failure: A Scientific Statement From the American Heart Association”. Circulation23 (2016): e535-e578.
  7. Stefan N. “Causes, consequences, and treatment of metabolically unhealthy fat distribution”. The Lancet Diabetes and Endocrinology 7 (2020): 616-627.
  8. O'Neill S and O'Driscoll L. “Metabolic syndrome: a closer look at the growing epidemic and its associated pathologies”. Obesity Reviews 1 (2015): 1-12.
  9. Lee CB., et al. “Economic fluctuations and cardiovascular diseases: A multiple-input time series analysis”. PLoS One8 (2019): e0219358.
  10. Spiteri J and Von Brockdorff P. “Economic development and health outcomes: Evidence from cardiovascular disease mortality in Europe”. Social Science and Medicine 224 (2019): 37-44.
  11. Zahra A., et al. “Cardiovascular disease and diabetes mortality, and their relation to socio-economical, environmental, and health behavioural factors in worldwide view”. Public Health 4 (2015): 385-395.
  12. Muka T., et al. “The global impact of non-communicable diseases on healthcare spending and national income: a systematic review”. European Journal of Epidemiology 4 (2015): 251-277.
  13. Sampson UK., et al. “Health promotion and cardiovascular disease prevention in sub-Saharan Africa”. Progress in Cardiovascular Diseases 3 (2013): 344-355.
  14. Mitri J and Pittas AG. “Vitamin D and diabetes”. Endocrinology and Metabolism Clinics of North America 1 (2014): 205-232.
  15. Maddaloni E., et al. “Vitamin D and Diabetes Mellitus”. Frontiers of Hormone Research 50 (2018): 161-176.
  16. Sacerdote A., et al. “Type 2 Diabetes Mellitus, Insulin Resistance, and Vitamin D”. Current Diabetes Reports 10 (2019): 101.
  17. Li X., et al. “Vitamin D and diabetes mellitus: Causal or casual association?” Reviews in Endocrine and Metabolic Disorders 2 (2017): 227-241.
  18. Xinyi Li., et al. “The Effect of Vitamin D Supplementation on Glycemic Control in Type 2 Diabetes Patients: A Systematic Review and Meta-Analysis”. Nutrients 3 (2018): 375.
  19. Lee WC., et al. “Vitamin D status and oxidative stress in diabetes mellitus”. Cellular and Molecular Biology 7 (2018): 60-69.
  20. The global burden of disease: 2004 update. Geneva, WHO (2008).
  21. United Nations Department of Economic and Social Affairs / Population Division. 2009. World Population Prospects (2008).
  22. World Health Organization. Average daily ambient ultraviolet radiation (UVR) level. World Health Data Platform/GHO/Indicator Metadata Registry List Average daily ambient ultraviolet radiation (UVR) level.
  23. World Population Prospects United Nations (2004): 2005-2010.
  24. Bhaven N Sampat PhD, “MPhil Academic Patents and Access to Medicines in Developing Countries”. American Journal of Public Health 1 (2009): 9-17.
  25. Gross National Happiness Commission. Royal Government of Bhutan.
  26. Global Health Observatory (GHO) data; Indicator and Measurement Registry version 1.7.0 BMI ≥ 25; total cholesterol ≥ 5.0; blood glucose ≥ 7.0; insufficiently active. WHO (World Health Organization) Percentage of defined population Program Country (2008).
  27. Food and Agriculture Organization of the United Nations”. Food Balance Sheets 2003-05.
  28. Afroz A., et al. “The impact of diabetes on the productivity and economy of Bangladesh”. BMJ Global Health 6 (2020): e002420.
  29. Meo SA., et al. “Prevalence of type 2 diabetes in the Arab world: impact of GDP and energy consumption”. European Review for Medical and Pharmacological Sciences 6 (2017): 1303-1312.
  30. Gassasse Z., et al. “Association between urbanisation and type 2 diabetes: an ecological study”. BMJ Global Health 2.4 (2017): e000473.
  31. Seuring T., et al. “The Economic Costs of Type 2 Diabetes: A Global Systematic Review”. Pharmacoeconomics8 (2015): 811-831.
  32. Bommer C., et al. “The global economic burden of diabetes in adults aged 20-79 years: a cost-of-illness study”. The Lancet Diabetes and Endocrinology 6 (2017): 423-430.
  33. Anjana RM., et al. “Prevalence of diabetes and prediabetes in 15 states of India: results from the ICMR-INDIAB population-based cross-sectional study.Collaborative Study Group”. The Lancet Diabetes and Endocrinology 8 (2017): 585-596.
  34. Bommer C., et al. “Global Economic Burden of Diabetes in Adults: Projections From 2015 to 2030”. Diabetes Care5 (2018): 963-970.
  35. Rinaldi G., et al. “Cost and cost-effectiveness of mHealth interventions for the prevention and control of type 2 diabetes mellitus: A systematic review”. Diabetes Research and Clinical Practice 162 (2020): 108084.
  36. Stenvers DJ., et al. “Circadian clocks and insulin resistance”. Nature Reviews Endocrinology 2 (2019): 75-89.
  37. Dong TA., et al. “The American Journal of Medicine 8 (2020): 901-907.
  38. Hall KD and Guo J. “Obesity Energetics: Body Weight Regulation and the Effects of Diet Composition”. Gastroenterology7 (2017): 1718-1727.
  39. Boivin DB and Boudreau P. “Impacts of shift work on sleep and circadian rhythms”. Pathologie Biologie 5 (2014): 292-301.
  40. Thosar SS., et al. “Role of the circadian system in cardiovascular disease”. Journal of Clinical Investigation 6 (2018): 2157-2167.
  41. Tordjman S., et al. “Melatonin: Pharmacology, Functions and Therapeutic Benefits”. Current Neuropharmacology 3 (2017): 434-443.
  42. Javeed N and Matveyenko AV. “Circadian Etiology of Type 2 Diabetes Mellitus”. Physiology 2 (2018): 138-150.
  43. Huang W., et al. “Circadian rhythms, sleep, and metabolism”. Journal of Clinical Investigation 6 (2011): 2133-2141.
  44. Qian J and Scheer FAJL. “Circadian System and Glucose Metabolism: Implications for Physiology and Disease”. Trends in Endocrinology and Metabolism 5 (2016): 282-293.
  45. Larcher S., et al. “Sleep habits and diabetes”. Diabetes and Metabolism 4 (2015): 263-271.
  46. Meyhöfer S., et al. “[Importance of sleep and circadian rhythm for energy metabolism]”. Internist2 (2019): 122-127.
  47. Lemmer B and Oster H. “The Role of Circadian Rhythms in the Hypertension of Diabetes Mellitus and the Metabolic Syndrome”. Current Hypertension Reports 5 (2018): 43.
  48. Nagorny C and Lyssenko V. “Tired of diabetes genetics? Circadian rhythms and diabetes: the MTNR1B story?” Current Diabetes Reports 6 (2012): 667-672.
  49. Radkevich LA., et al. “Determinants of the Happiness Index, Life Expectancy, Incidence and Dietary Patterns in Different Countries”. Journal of Obesity and Chronic Diseases1 (2018): 26-36.
  50. Lyudmila Alexandrovna Radkevich and Dariya Andreyevna Radkevich. “Study of Non-Communicable Chronic Diseases Structure and Risk Factors in European and Mediterranean Countries (Population Study)”. EC Pharmacology and Toxicology12 (2020): 32-46.
  51. Radkevich LA and Radkevich DA. “C Comparative Analysis of Economic, Geographic, Social and Nutritional Risk Factors 4 Types of Non-Communicable Chronic Diseases (Melanoma, Multiple Sclerosis, Diabetes Mellitus and Hypertensive Heart Disease) in the Mediterranean and Caribbean Countries (Population Study)”. Journal of Obesity and Chronic Diseases 2 (2020): 51-58.
Citation: Lyudmila Alexandrovna Radkevich and Dariya Andreyevna Radkevich. “Dietary Patterns and Economic and Geographic Risk Factors for the Burden of Diabetes Mellitus (Observational Study)”. EC Diabetes and Metabolic Research 5.4 (2021): 82-96.

PubMed Indexed Article


EC Pharmacology and Toxicology
LC-UV-MS and MS/MS Characterize Glutathione Reactivity with Different Isomers (2,2' and 2,4' vs. 4,4') of Methylene Diphenyl-Diisocyanate.

PMID: 31143884 [PubMed]

PMCID: PMC6536005


EC Pharmacology and Toxicology
Alzheimer's Pathogenesis, Metal-Mediated Redox Stress, and Potential Nanotheranostics.

PMID: 31565701 [PubMed]

PMCID: PMC6764777


EC Neurology
Differences in Rate of Cognitive Decline and Caregiver Burden between Alzheimer's Disease and Vascular Dementia: a Retrospective Study.

PMID: 27747317 [PubMed]

PMCID: PMC5065347


EC Pharmacology and Toxicology
Will Blockchain Technology Transform Healthcare and Biomedical Sciences?

PMID: 31460519 [PubMed]

PMCID: PMC6711478


EC Pharmacology and Toxicology
Is it a Prime Time for AI-powered Virtual Drug Screening?

PMID: 30215059 [PubMed]

PMCID: PMC6133253


EC Psychology and Psychiatry
Analysis of Evidence for the Combination of Pro-dopamine Regulator (KB220PAM) and Naltrexone to Prevent Opioid Use Disorder Relapse.

PMID: 30417173 [PubMed]

PMCID: PMC6226033


EC Anaesthesia
Arrest Under Anesthesia - What was the Culprit? A Case Report.

PMID: 30264037 [PubMed]

PMCID: PMC6155992


EC Orthopaedics
Distraction Implantation. A New Technique in Total Joint Arthroplasty and Direct Skeletal Attachment.

PMID: 30198026 [PubMed]

PMCID: PMC6124505


EC Pulmonology and Respiratory Medicine
Prevalence and factors associated with self-reported chronic obstructive pulmonary disease among adults aged 40-79: the National Health and Nutrition Examination Survey (NHANES) 2007-2012.

PMID: 30294723 [PubMed]

PMCID: PMC6169793


EC Dental Science
Important Dental Fiber-Reinforced Composite Molding Compound Breakthroughs

PMID: 29285526 [PubMed]

PMCID: PMC5743211


EC Microbiology
Prevalence of Intestinal Parasites Among HIV Infected and HIV Uninfected Patients Treated at the 1o De Maio Health Centre in Maputo, Mozambique

PMID: 29911204 [PubMed]

PMCID: PMC5999047


EC Microbiology
Macrophages and the Viral Dissemination Super Highway

PMID: 26949751 [PubMed]

PMCID: PMC4774560


EC Microbiology
The Microbiome, Antibiotics, and Health of the Pediatric Population.

PMID: 27390782 [PubMed]

PMCID: PMC4933318


EC Microbiology
Reactive Oxygen Species in HIV Infection

PMID: 28580453 [PubMed]

PMCID: PMC5450819


EC Microbiology
A Review of the CD4 T Cell Contribution to Lung Infection, Inflammation and Repair with a Focus on Wheeze and Asthma in the Pediatric Population

PMID: 26280024 [PubMed]

PMCID: PMC4533840


EC Neurology
Identifying Key Symptoms Differentiating Myalgic Encephalomyelitis and Chronic Fatigue Syndrome from Multiple Sclerosis

PMID: 28066845 [PubMed]

PMCID: PMC5214344


EC Pharmacology and Toxicology
Paradigm Shift is the Normal State of Pharmacology

PMID: 28936490 [PubMed]

PMCID: PMC5604476


EC Neurology
Examining those Meeting IOM Criteria Versus IOM Plus Fibromyalgia

PMID: 28713879 [PubMed]

PMCID: PMC5510658


EC Neurology
Unilateral Frontosphenoid Craniosynostosis: Case Report and a Review of the Literature

PMID: 28133641 [PubMed]

PMCID: PMC5267489


EC Ophthalmology
OCT-Angiography for Non-Invasive Monitoring of Neuronal and Vascular Structure in Mouse Retina: Implication for Characterization of Retinal Neurovascular Coupling

PMID: 29333536 [PubMed]

PMCID: PMC5766278


EC Neurology
Longer Duration of Downslope Treadmill Walking Induces Depression of H-Reflexes Measured during Standing and Walking.

PMID: 31032493 [PubMed]

PMCID: PMC6483108


EC Microbiology
Onchocerciasis in Mozambique: An Unknown Condition for Health Professionals.

PMID: 30957099 [PubMed]

PMCID: PMC6448571


EC Nutrition
Food Insecurity among Households with and without Podoconiosis in East and West Gojjam, Ethiopia.

PMID: 30101228 [PubMed]

PMCID: PMC6086333


EC Ophthalmology
REVIEW. +2 to +3 D. Reading Glasses to Prevent Myopia.

PMID: 31080964 [PubMed]

PMCID: PMC6508883


EC Gynaecology
Biomechanical Mapping of the Female Pelvic Floor: Uterine Prolapse Versus Normal Conditions.

PMID: 31093608 [PubMed]

PMCID: PMC6513001


EC Dental Science
Fiber-Reinforced Composites: A Breakthrough in Practical Clinical Applications with Advanced Wear Resistance for Dental Materials.

PMID: 31552397 [PubMed]

PMCID: PMC6758937


EC Microbiology
Neurocysticercosis in Child Bearing Women: An Overlooked Condition in Mozambique and a Potentially Missed Diagnosis in Women Presenting with Eclampsia.

PMID: 31681909 [PubMed]

PMCID: PMC6824723


EC Microbiology
Molecular Detection of Leptospira spp. in Rodents Trapped in the Mozambique Island City, Nampula Province, Mozambique.

PMID: 31681910 [PubMed]

PMCID: PMC6824726


EC Neurology
Endoplasmic Reticulum-Mitochondrial Cross-Talk in Neurodegenerative and Eye Diseases.

PMID: 31528859 [PubMed]

PMCID: PMC6746603


EC Psychology and Psychiatry
Can Chronic Consumption of Caffeine by Increasing D2/D3 Receptors Offer Benefit to Carriers of the DRD2 A1 Allele in Cocaine Abuse?

PMID: 31276119 [PubMed]

PMCID: PMC6604646


EC Anaesthesia
Real Time Locating Systems and sustainability of Perioperative Efficiency of Anesthesiologists.

PMID: 31406965 [PubMed]

PMCID: PMC6690616


EC Pharmacology and Toxicology
A Pilot STEM Curriculum Designed to Teach High School Students Concepts in Biochemical Engineering and Pharmacology.

PMID: 31517314 [PubMed]

PMCID: PMC6741290


EC Pharmacology and Toxicology
Toxic Mechanisms Underlying Motor Activity Changes Induced by a Mixture of Lead, Arsenic and Manganese.

PMID: 31633124 [PubMed]

PMCID: PMC6800226


EC Neurology
Research Volunteers' Attitudes Toward Chronic Fatigue Syndrome and Myalgic Encephalomyelitis.

PMID: 29662969 [PubMed]

PMCID: PMC5898812


EC Pharmacology and Toxicology
Hyperbaric Oxygen Therapy for Alzheimer's Disease.

PMID: 30215058 [PubMed]

PMCID: PMC6133268


News and Events


December Issue Release

We always feel pleasure to share our updates with you all. Here, notifying you that we have successfully released the December issue of respective journals and the latest articles can be viewed on the current issue pages.

Submission Deadline for Upcoming Issue

ECronicon delightfully welcomes all the authors around the globe for effective collaboration with an article submission for the upcoming issue of respective journals. Submissions are accepted on/before December 17, 2021.

Certificate of Publication

ECronicon honors with a "Publication Certificate" to the corresponding author by including the names of co-authors as a token of appreciation for publishing the work with our respective journals.

Best Article of the Issue

Editors of respective journals will always be very much interested in electing one Best Article after each issue release. The authors of the selected article will be honored with a "Best Article of the Issue" certificate.

Certifying for Review

ECronicon certifies the Editors for their first review done towards the assigned article of the respective journals.

Latest Articles

The latest articles will be updated immediately on the articles in press page of the respective journals.

Immediate Assistance

The prime motto of this team is to clarify all the queries without any delay or hesitation to avoid the inconvenience. For immediate assistance on your queries please don't hesitate to drop an email to editor@ecronicon.uk